The Ensign Group, Inc.
The Ensign Group, Inc. ENSG Peers
See (ENSG) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENSG | $143.56 | +1.41% | 8.25B | 27.09 | $5.30 | +0.17% |
| HCA | $368.25 | +1.37% | 88.59B | 16.34 | $22.53 | +0.73% |
| FMS | $28.01 | -0.37% | 16.43B | 23.53 | $1.19 | +2.26% |
| THC | $157.82 | +2.10% | 14.66B | 10.12 | $15.60 | N/A |
| SOLV | $73.48 | -1.76% | 12.71B | 26.62 | $2.76 | N/A |
| UHS | $192.32 | +0.40% | 12.39B | 10.80 | $17.80 | +0.41% |
| EHC | $117.53 | +0.51% | 11.85B | 24.18 | $4.86 | +0.56% |
| DVA | $143.95 | -0.33% | 11.06B | 13.42 | $10.73 | N/A |
| OSH | $39.00 | +0.08% | 9.52B | -17.65 | -$2.21 | N/A |
| CHE | $557.15 | -2.10% | 8.15B | 27.18 | $20.50 | +0.34% |
Stock Comparison
ENSG vs HCA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, HCA has a market cap of 88.59B. Regarding current trading prices, ENSG is priced at $143.56, while HCA trades at $368.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas HCA's P/E ratio is 16.34. In terms of profitability, ENSG's ROE is +0.17%, compared to HCA's ROE of -2.36%. Regarding short-term risk, ENSG is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs FMS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, FMS has a market cap of 16.43B. Regarding current trading prices, ENSG is priced at $143.56, while FMS trades at $28.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas FMS's P/E ratio is 23.53. In terms of profitability, ENSG's ROE is +0.17%, compared to FMS's ROE of +0.04%. Regarding short-term risk, ENSG is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs THC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, THC has a market cap of 14.66B. Regarding current trading prices, ENSG is priced at $143.56, while THC trades at $157.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas THC's P/E ratio is 10.12. In terms of profitability, ENSG's ROE is +0.17%, compared to THC's ROE of +0.37%. Regarding short-term risk, ENSG is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs SOLV Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, SOLV has a market cap of 12.71B. Regarding current trading prices, ENSG is priced at $143.56, while SOLV trades at $73.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas SOLV's P/E ratio is 26.62. In terms of profitability, ENSG's ROE is +0.17%, compared to SOLV's ROE of +0.15%. Regarding short-term risk, ENSG is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs UHS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, UHS has a market cap of 12.39B. Regarding current trading prices, ENSG is priced at $143.56, while UHS trades at $192.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas UHS's P/E ratio is 10.80. In terms of profitability, ENSG's ROE is +0.17%, compared to UHS's ROE of +0.18%. Regarding short-term risk, ENSG is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs EHC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, EHC has a market cap of 11.85B. Regarding current trading prices, ENSG is priced at $143.56, while EHC trades at $117.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas EHC's P/E ratio is 24.18. In terms of profitability, ENSG's ROE is +0.17%, compared to EHC's ROE of +0.25%. Regarding short-term risk, ENSG is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs DVA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, DVA has a market cap of 11.06B. Regarding current trading prices, ENSG is priced at $143.56, while DVA trades at $143.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas DVA's P/E ratio is 13.42. In terms of profitability, ENSG's ROE is +0.17%, compared to DVA's ROE of +3.94%. Regarding short-term risk, ENSG is less volatile compared to DVA. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs OSH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, OSH has a market cap of 9.52B. Regarding current trading prices, ENSG is priced at $143.56, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas OSH's P/E ratio is -17.65. In terms of profitability, ENSG's ROE is +0.17%, compared to OSH's ROE of +4.64%. Regarding short-term risk, ENSG is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CHE Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CHE has a market cap of 8.15B. Regarding current trading prices, ENSG is priced at $143.56, while CHE trades at $557.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CHE's P/E ratio is 27.18. In terms of profitability, ENSG's ROE is +0.17%, compared to CHE's ROE of +0.26%. Regarding short-term risk, ENSG is less volatile compared to CHE. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs LHCG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, LHCG has a market cap of 5.29B. Regarding current trading prices, ENSG is priced at $143.56, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas LHCG's P/E ratio is 82.83. In terms of profitability, ENSG's ROE is +0.17%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, ENSG is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs OPCH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, OPCH has a market cap of 5.17B. Regarding current trading prices, ENSG is priced at $143.56, while OPCH trades at $31.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas OPCH's P/E ratio is 25.25. In terms of profitability, ENSG's ROE is +0.17%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, ENSG is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMED Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AMED has a market cap of 3.10B. Regarding current trading prices, ENSG is priced at $143.56, while AMED trades at $94.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AMED's P/E ratio is 34.87. In terms of profitability, ENSG's ROE is +0.17%, compared to AMED's ROE of +0.10%. Regarding short-term risk, ENSG is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs SGRY Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, SGRY has a market cap of 3.05B. Regarding current trading prices, ENSG is priced at $143.56, while SGRY trades at $23.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas SGRY's P/E ratio is -18.02. In terms of profitability, ENSG's ROE is +0.17%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, ENSG is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs ACHC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, ACHC has a market cap of 2.48B. Regarding current trading prices, ENSG is priced at $143.56, while ACHC trades at $26.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas ACHC's P/E ratio is 9.69. In terms of profitability, ENSG's ROE is +0.17%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs LFST Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, LFST has a market cap of 2.28B. Regarding current trading prices, ENSG is priced at $143.56, while LFST trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas LFST's P/E ratio is -65.22. In terms of profitability, ENSG's ROE is +0.17%, compared to LFST's ROE of -0.02%. Regarding short-term risk, ENSG is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ARDT Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, ARDT has a market cap of 2.08B. Regarding current trading prices, ENSG is priced at $143.56, while ARDT trades at $14.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas ARDT's P/E ratio is 8.65. In terms of profitability, ENSG's ROE is +0.17%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, ENSG is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs ADUS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, ADUS has a market cap of 2.02B. Regarding current trading prices, ENSG is priced at $143.56, while ADUS trades at $109.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas ADUS's P/E ratio is 24.83. In terms of profitability, ENSG's ROE is +0.17%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, ENSG is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs SEM Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, SEM has a market cap of 1.94B. Regarding current trading prices, ENSG is priced at $143.56, while SEM trades at $15.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas SEM's P/E ratio is 24.29. In terms of profitability, ENSG's ROE is +0.17%, compared to SEM's ROE of +0.10%. Regarding short-term risk, ENSG is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMEH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AMEH has a market cap of 1.83B. Regarding current trading prices, ENSG is priced at $143.56, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AMEH's P/E ratio is 39.25. In terms of profitability, ENSG's ROE is +0.17%, compared to AMEH's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs NHC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, NHC has a market cap of 1.62B. Regarding current trading prices, ENSG is priced at $143.56, while NHC trades at $105.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas NHC's P/E ratio is 16.08. In terms of profitability, ENSG's ROE is +0.17%, compared to NHC's ROE of +0.11%. Regarding short-term risk, ENSG is less volatile compared to NHC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs BKD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, BKD has a market cap of 1.62B. Regarding current trading prices, ENSG is priced at $143.56, while BKD trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas BKD's P/E ratio is -6.65. In terms of profitability, ENSG's ROE is +0.17%, compared to BKD's ROE of -0.96%. Regarding short-term risk, ENSG is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ASTH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, ASTH has a market cap of 1.50B. Regarding current trading prices, ENSG is priced at $143.56, while ASTH trades at $26.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas ASTH's P/E ratio is 29.67. In terms of profitability, ENSG's ROE is +0.17%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, ENSG is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs MD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, MD has a market cap of 1.24B. Regarding current trading prices, ENSG is priced at $143.56, while MD trades at $14.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas MD's P/E ratio is -14.42. In terms of profitability, ENSG's ROE is +0.17%, compared to MD's ROE of -0.11%. Regarding short-term risk, ENSG is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs BKDT Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, BKDT has a market cap of 1.23B. Regarding current trading prices, ENSG is priced at $143.56, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas BKDT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, ENSG is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs USPH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, USPH has a market cap of 1.17B. Regarding current trading prices, ENSG is priced at $143.56, while USPH trades at $77.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas USPH's P/E ratio is 41.96. In terms of profitability, ENSG's ROE is +0.17%, compared to USPH's ROE of +0.06%. Regarding short-term risk, ENSG is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs AVAH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AVAH has a market cap of 1.14B. Regarding current trading prices, ENSG is priced at $143.56, while AVAH trades at $5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AVAH's P/E ratio is -97.67. In terms of profitability, ENSG's ROE is +0.17%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, ENSG is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AGL Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AGL has a market cap of 1.11B. Regarding current trading prices, ENSG is priced at $143.56, while AGL trades at $2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AGL's P/E ratio is -4.33. In terms of profitability, ENSG's ROE is +0.17%, compared to AGL's ROE of -0.44%. Regarding short-term risk, ENSG is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs HCSG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, HCSG has a market cap of 1.06B. Regarding current trading prices, ENSG is priced at $143.56, while HCSG trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas HCSG's P/E ratio is 26.40. In terms of profitability, ENSG's ROE is +0.17%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, ENSG is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs PNTG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, PNTG has a market cap of 1.01B. Regarding current trading prices, ENSG is priced at $143.56, while PNTG trades at $29.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas PNTG's P/E ratio is 41.67. In terms of profitability, ENSG's ROE is +0.17%, compared to PNTG's ROE of +0.12%. Regarding short-term risk, ENSG is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMN Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AMN has a market cap of 830.01M. Regarding current trading prices, ENSG is priced at $143.56, while AMN trades at $21.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AMN's P/E ratio is -5.63. In terms of profitability, ENSG's ROE is +0.17%, compared to AMN's ROE of -0.21%. Regarding short-term risk, ENSG is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TALKW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, TALKW has a market cap of 657.08M. Regarding current trading prices, ENSG is priced at $143.56, while TALKW trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas TALKW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, ENSG is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs INNV Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, INNV has a market cap of 534.65M. Regarding current trading prices, ENSG is priced at $143.56, while INNV trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas INNV's P/E ratio is -20.84. In terms of profitability, ENSG's ROE is +0.17%, compared to INNV's ROE of -0.12%. Regarding short-term risk, ENSG is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CYH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CYH has a market cap of 534.57M. Regarding current trading prices, ENSG is priced at $143.56, while CYH trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CYH's P/E ratio is -1.04. In terms of profitability, ENSG's ROE is +0.17%, compared to CYH's ROE of +0.30%. Regarding short-term risk, ENSG is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs EHAB Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, EHAB has a market cap of 529.92M. Regarding current trading prices, ENSG is priced at $143.56, while EHAB trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas EHAB's P/E ratio is -3.36. In terms of profitability, ENSG's ROE is +0.17%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, ENSG is less volatile compared to EHAB. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TALK Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, TALK has a market cap of 513.82M. Regarding current trading prices, ENSG is priced at $143.56, while TALK trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas TALK's P/E ratio is 307.00. In terms of profitability, ENSG's ROE is +0.17%, compared to TALK's ROE of -0.04%. Regarding short-term risk, ENSG is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AUNA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AUNA has a market cap of 510.32M. Regarding current trading prices, ENSG is priced at $143.56, while AUNA trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AUNA's P/E ratio is 15.67. In terms of profitability, ENSG's ROE is +0.17%, compared to AUNA's ROE of +0.07%. Regarding short-term risk, ENSG is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs SNDA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, SNDA has a market cap of 507.86M. Regarding current trading prices, ENSG is priced at $143.56, while SNDA trades at $26.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas SNDA's P/E ratio is -49.85. In terms of profitability, ENSG's ROE is +0.17%, compared to SNDA's ROE of -0.03%. Regarding short-term risk, ENSG is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CCRN Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CCRN has a market cap of 457.33M. Regarding current trading prices, ENSG is priced at $143.56, while CCRN trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CCRN's P/E ratio is -31.70. In terms of profitability, ENSG's ROE is +0.17%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, ENSG is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CMPS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CMPS has a market cap of 362.11M. Regarding current trading prices, ENSG is priced at $143.56, while CMPS trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CMPS's P/E ratio is -1.70. In terms of profitability, ENSG's ROE is +0.17%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, ENSG is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CSU Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CSU has a market cap of 223.71M. Regarding current trading prices, ENSG is priced at $143.56, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CSU's P/E ratio is 0.67. In terms of profitability, ENSG's ROE is +0.17%, compared to CSU's ROE of +2.23%. Regarding short-term risk, ENSG is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AIRS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AIRS has a market cap of 206.91M. Regarding current trading prices, ENSG is priced at $143.56, while AIRS trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AIRS's P/E ratio is -12.14. In terms of profitability, ENSG's ROE is +0.17%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, ENSG is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TOI Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, TOI has a market cap of 200.75M. Regarding current trading prices, ENSG is priced at $143.56, while TOI trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas TOI's P/E ratio is -3.73. In terms of profitability, ENSG's ROE is +0.17%, compared to TOI's ROE of -2.73%. Regarding short-term risk, ENSG is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AONC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AONC has a market cap of 175.50M. Regarding current trading prices, ENSG is priced at $143.56, while AONC trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AONC's P/E ratio is -6.74. In terms of profitability, ENSG's ROE is +0.17%, compared to AONC's ROE of +0.25%. Regarding short-term risk, ENSG is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs JYNT Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, JYNT has a market cap of 154.41M. Regarding current trading prices, ENSG is priced at $143.56, while JYNT trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas JYNT's P/E ratio is -100.90. In terms of profitability, ENSG's ROE is +0.17%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, ENSG is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs BTMD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, BTMD has a market cap of 149.73M. Regarding current trading prices, ENSG is priced at $143.56, while BTMD trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas BTMD's P/E ratio is 43.44. In terms of profitability, ENSG's ROE is +0.17%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, ENSG is more volatile compared to BTMD. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs DCGO Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, DCGO has a market cap of 148.66M. Regarding current trading prices, ENSG is priced at $143.56, while DCGO trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas DCGO's P/E ratio is 8.33. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, ENSG is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs FVE Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, FVE has a market cap of 98.39M. Regarding current trading prices, ENSG is priced at $143.56, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas FVE's P/E ratio is -5.64. In terms of profitability, ENSG's ROE is +0.17%, compared to FVE's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs PIIIW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, PIIIW has a market cap of 60.69M. Regarding current trading prices, ENSG is priced at $143.56, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to PIIIW's ROE of -1.07%. Regarding short-term risk, ENSG is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs PIII Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, PIII has a market cap of 58.82M. Regarding current trading prices, ENSG is priced at $143.56, while PIII trades at $8.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas PIII's P/E ratio is -0.15. In terms of profitability, ENSG's ROE is +0.17%, compared to PIII's ROE of -1.07%. Regarding short-term risk, ENSG is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ALR Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, ALR has a market cap of 44.18M. Regarding current trading prices, ENSG is priced at $143.56, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas ALR's P/E ratio is -1.11. In terms of profitability, ENSG's ROE is +0.17%, compared to ALR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CCEL Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CCEL has a market cap of 40.80M. Regarding current trading prices, ENSG is priced at $143.56, while CCEL trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CCEL's P/E ratio is 504.76. In terms of profitability, ENSG's ROE is +0.17%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, ENSG is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs IMAC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, IMAC has a market cap of 33.08M. Regarding current trading prices, ENSG is priced at $143.56, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas IMAC's P/E ratio is -2.27. In terms of profitability, ENSG's ROE is +0.17%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, ENSG is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs KDLYW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, KDLYW has a market cap of 25.20M. Regarding current trading prices, ENSG is priced at $143.56, while KDLYW trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas KDLYW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, ENSG is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AMS has a market cap of 17.84M. Regarding current trading prices, ENSG is priced at $143.56, while AMS trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AMS's P/E ratio is 8.38. In terms of profitability, ENSG's ROE is +0.17%, compared to AMS's ROE of +0.09%. Regarding short-term risk, ENSG is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs MODV Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, MODV has a market cap of 16.65M. Regarding current trading prices, ENSG is priced at $143.56, while MODV trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas MODV's P/E ratio is -0.08. In terms of profitability, ENSG's ROE is +0.17%, compared to MODV's ROE of +6.87%. Regarding short-term risk, ENSG is less volatile compared to MODV. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AIH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, AIH has a market cap of 15.93M. Regarding current trading prices, ENSG is priced at $143.56, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas AIH's P/E ratio is -2.78. In terms of profitability, ENSG's ROE is +0.17%, compared to AIH's ROE of -0.79%. Regarding short-term risk, ENSG is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CANO Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CANO has a market cap of 12.43M. Regarding current trading prices, ENSG is priced at $143.56, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CANO's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to CANO's ROE of -32.61%. Regarding short-term risk, ENSG is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs FTRP Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, FTRP has a market cap of 9.81M. Regarding current trading prices, ENSG is priced at $143.56, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas FTRP's P/E ratio is -1.22. In terms of profitability, ENSG's ROE is +0.17%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, ENSG is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs MNDR Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, MNDR has a market cap of 5.98M. Regarding current trading prices, ENSG is priced at $143.56, while MNDR trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas MNDR's P/E ratio is -0.31. In terms of profitability, ENSG's ROE is +0.17%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, ENSG and MNDR have similar daily volatility (2.86).
ENSG vs GBNH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, GBNH has a market cap of 5.52M. Regarding current trading prices, ENSG is priced at $143.56, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas GBNH's P/E ratio is -0.06. In terms of profitability, ENSG's ROE is +0.17%, compared to GBNH's ROE of +0.51%. Regarding short-term risk, ENSG is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TOIIW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, TOIIW has a market cap of 5.23M. Regarding current trading prices, ENSG is priced at $143.56, while TOIIW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas TOIIW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TOIIW's ROE of -2.73%. Regarding short-term risk, ENSG is more volatile compared to TOIIW. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs RHE Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, RHE has a market cap of 5.21M. Regarding current trading prices, ENSG is priced at $143.56, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas RHE's P/E ratio is -1.79. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE's ROE of +2.66%. Regarding short-term risk, ENSG is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ATIP Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, ATIP has a market cap of 3.66M. Regarding current trading prices, ENSG is priced at $143.56, while ATIP trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas ATIP's P/E ratio is -0.04. In terms of profitability, ENSG's ROE is +0.17%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, ENSG is more volatile compared to ATIP. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs IMACW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, IMACW has a market cap of 1.74M. Regarding current trading prices, ENSG is priced at $143.56, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas IMACW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, ENSG is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CCM Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, CCM has a market cap of 1.26M. Regarding current trading prices, ENSG is priced at $143.56, while CCM trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas CCM's P/E ratio is -0.90. In terms of profitability, ENSG's ROE is +0.17%, compared to CCM's ROE of +0.13%. Regarding short-term risk, ENSG is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs SYRA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, SYRA has a market cap of 1.07M. Regarding current trading prices, ENSG is priced at $143.56, while SYRA trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas SYRA's P/E ratio is -0.18. In terms of profitability, ENSG's ROE is +0.17%, compared to SYRA's ROE of -1.28%. Regarding short-term risk, ENSG is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs RHE-PA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, RHE-PA has a market cap of 674535.00. Regarding current trading prices, ENSG is priced at $143.56, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE-PA's ROE of +2.66%. Regarding short-term risk, ENSG is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs BACK Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, BACK has a market cap of 119605.00. Regarding current trading prices, ENSG is priced at $143.56, while BACK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas BACK's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to BACK's ROE of +2.46%. Regarding short-term risk, ENSG is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs NVOS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, NVOS has a market cap of 39460.00. Regarding current trading prices, ENSG is priced at $143.56, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas NVOS's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, ENSG is less volatile compared to NVOS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs NIVFW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, NIVFW has a market cap of 1579.00. Regarding current trading prices, ENSG is priced at $143.56, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas NIVFW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, ENSG is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs IONM Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.25B. In comparison, IONM has a market cap of 313.00. Regarding current trading prices, ENSG is priced at $143.56, while IONM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 27.09, whereas IONM's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to IONM's ROE of +0.75%. Regarding short-term risk, ENSG is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.